In line with the latter, CCRL2, an atypical chemokine receptor which dimerizes with CXCR2, is upregulated in MDS and secondary AML, and CCRL2 plays a role in cell growth and clonogenicity, partially through JAK2/STAT signaling [88]. Here, JAK2 is linked to acute myeloid leukemia.